You are here
Publication: Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection
Dr. Pamela Melton is a coauthor on "Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center" published in Journal of Racial and Ethnic Health Disparities.
This study aimed to assess time to hepatitis C (HCV) treatment (i.e., the time between the initial clinic visit for HCV evaluation and the HCV treatment start date), to compare clinical characteristics between patients who received HCV treatment ≥ and < 6 months, and to identify predictors of longer time to HCV treatment in patients living with HCV.